TGFB1 and COVID-19: The concentrations of NT-PCP-III (p < 0.001) and TGF-β1 (p < 0.001) were significantly elevated in BALF from COVID-19 ARDS patients compared with non-ARDS patients (Fig. 2C, 2D).